“If you choose to use HT to prevent chronic conditions,
it may be in your best interest to also choose to talk to
your health care provider about this”.Meno Martha
Umbrella
What may the Hormone Therapy 2022 Update for Chronic Conditions Umbrella include?
Depending on the Source (DotS) this Umbrella may include:
- Chronic Conditions/Diseases/Illnesses
- Hormone Replacement Therapy (HRT)
- Hormone Therapy (HT)
- Hormone Therapy and Cancer
- Hormone Therapy and Dementia
- Hormone Therapy and Heart Disease and Stroke (Cardiovascular Disease)
- Hormone Therapy and Osteoporosis
- Menopausal Hormone Therapy (MHT)
Date
What can it be important to be clear about with hormone therapy (HT) information?
It can be important to be clear about the date of all information including the date of HT information, because this information may have been updated.
Symptoms or Chronic Conditions
What can it also be important to be clear about with HT information?
It can also be important to be clear about whether HT information is about the use of HT for the management of menopausal symptoms such as hot flushes, night sweats and vaginal dryness; or for the prevention of chronic conditions such as cardiovascular disease, cancer and osteoporosis.
2017 Recommendations Update
When did the (United States) Preventative Services Task Force (USPSTF) update their 2017 recommendations on the use of HT in postmenopausal women for the primary prevention of chronic conditions?
The USPSTF updated their 2017 recommendations on 01 November 2022.
2022 Recommendations
What did the USPSTF’s 2022 recommendations include?
In Hormone Therapy In Postmenopausal Persons: Primary Prevention of Chronic Conditions – Recommendation Summary, the USPSTF recommend:
The USPSTF recommends against the use of combined estrogen and progestin for the primary prevention of chronic conditions in postmenopausal persons”.1
In Hormone Therapy In Postmenopausal Persons: Primary Prevention of Chronic Conditions – Recommendation Summary, the USPSTF recommended:
The USPSTF recommends against the use of estrogen alone for the primary prevention of chronic conditions in postmenopausal persons who have had a hysterectomy”.2
Recommendation Applies To
To whom does the USPSTF’s 2022 recommendation apply?
In Hormone Therapy In Postmenopausal Persons: Primary Prevention of Chronic Conditions – Clinician Summary: To Whom Does This Recommendation Apply the USPSTF note:
Health Care Provider
What if I choose to use HT to prevent chronic conditions?
If you choose to use HT to prevent chronic conditions, it may be in your best interest to also choose to talk to your health care provider about this.
Health Topics A-Z
Where may I find Health Topics A-Z related to Hormone Therapy 2022 Update for Chronic Conditions?
In Health Topics A-Z you may find:
Health Topics A-Z
- Hormone Therapy
- Hormone Therapy Alternatives
- Hormone Therapy Benefits and Risks
- Hormone Therapy Postmenopause
- Hormone Therapy Videos
- Hormone Therapy and Estrogen Plus Progestogen Therapy
- Hormone Therapy and Estrogen Therapy
- Menopause Videos 2026
- Postmenopause
- Postmenopause and Chronic Disease Prevention
Links
Where may I find Links related to Hormone Therapy 2022 Update for Chronic Conditions?
Your Country may have Links similar to:
Links
This Links List to third party websites is neither comprehensive nor exhaustive. Inclusion on this Links List does not imply endorsement or recommendation. Non-inclusion on this Links List does not imply non-endorsement or non-recommendation. Third party websites are not under the control of Meno Martha International Menopause Directory. Third party websites may contain explicit medical images and/or sexual references. Please read Meno Martha International Menopause Directory’s Links Policy before proceeding to a Link. Please contact Webmaster if you experience a problem with a Link.New or Updated
Sources
Where may I find the Sources quoted?
You may find the Sources quoted at:
Sources
- Hormone Therapy In Postmenopausal Women: Primary Prevention of Chronic Conditions – Recommendation Summary. 01 November 2022. U.S. Preventative Services Task Force https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication Accessed: 15 June 2026
- Hormone Therapy In Postmenopausal Women: Primary Prevention of Chronic Conditions – Recommendation Summary. 01 November 2022. U.S. Preventative Services Task Force https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication Accessed:
- Hormone Therapy In Postmenopausal Women: Primary Prevention of Chronic Condit15 June 2026ions – Clinician Summary: To Whom Does This Recommendation Apply. 01 November 2022. U.S. Preventative Services Task Force https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/menopausal-hormone-therapy-preventive-medication Accessed: 15 June 2026
Topic Last Updated: 15 June 2026 – Topic Last Reviewed: 15 June 2026
